*DJ Nestle Now Has Around 84% of Aimmune Therapeutics Shares
(MORE TO FOLLOW) Dow Jones Newswires
October 13, 2020 01:18 ET (05:18 GMT)
*DJ Nestle's Subsidiary SPN MergerSub Offered $34.5 for Each Aimmune Therapeutics Share Not Owned by Nestle
(MORE TO FOLLOW) Dow Jones Newswires
October 13, 2020 01:21 ET (05:21 GMT)
*DJ Nestle: Minimum Tender Condition Has Been Satisfied
(MORE TO FOLLOW) Dow Jones Newswires
October 13, 2020 01:22 ET (05:22 GMT)
*DJ Nestle Wants to Merge SPN MergerSub Subsidiary With Aimmune Therapeutics
(MORE TO FOLLOW) Dow Jones Newswires
October 13, 2020 01:24 ET (05:24 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.